Search
Now showing items 1-1 of 1
Postmarketing study of efficacy and safety of losartan during the treatment of patients with mild and moderate hypertension: Lothar study / Postmarketinška studija efikasnosti i bezbednosti primene losartana u lečenju bolesnika s umerenom i blagom arterijskom hipertenzijom - studija Lotnar
(Srpsko lekarsko društvo, Beograd, 2013)
Introduction. Losartan, the angiotensin type 1 receptor blocker (ARB) exercises its main antihypertensive effect by vasodilatation of peripheral arteries. Objective. The aim of this study was to evaluate the antihypertensive ...